Our approach
Cytolix Labs Private Limited respects the confidentiality of business partners, healthcare institutions, distributors, patients and website visitors. This policy explains how we handle information received through this website and our published email addresses.
Information we collect
We may receive names, business contact details, company and regulatory information, product or portfolio details, institutional requirements, distributor credentials, and the contents of messages or documents you choose to send.
How we use information
We use submitted information to respond to enquiries, assess potential partnerships, evaluate regulatory or supply requirements, manage pharmacovigilance and product complaints, protect our legal interests, and comply with applicable obligations.
Special categories and safety reports
Do not submit patient-identifiable medical information through a general business form. Adverse events and product complaints should be sent to pharmacovigilance@cytolix.com. Safety information may need to be retained and shared with relevant manufacturers or authorities as required by law.
Sharing and international correspondence
We do not sell personal information. We may share information with professional advisers, service providers, regulatory authorities, or relevant manufacturing partners where necessary for the purpose of the enquiry and subject to appropriate confidentiality controls.
Retention and security
Information is retained only as long as reasonably needed for the relevant business, regulatory, safety, or legal purpose. Email transmission is not completely secure; confidential dossiers should be exchanged through an agreed secure channel after initial contact.
Your choices
You may ask us to correct or delete general enquiry information, subject to legal and regulatory retention requirements. Contact privacy@cytolix.com.